Empirical therapy for encephalitis
Start aciclovir therapy in all patients with suspected acute encephalitis while further investigations are underway, because herpes simplex virus (HSV) is the most common treatable cause.
In adults and children 1 month and older with suspected acute encephalitis, use:
aciclovir intravenously, 8-hourlyacicloviraciclovir aciclovir
adult and child older than 12 years: 10 mg/kg1. For dosage adjustment in adults with kidney impairment, see aciclovir intravenous dosage adjustment
Add treatment with antibiotics for patients with suspected acute encephalitis in whom bacterial meningitis or sepsis is possible – see Meningitis in adults and children 2 months or older or Meningitis in neonates and children younger than 2 months.
For management of neonates with suspected herpes simplex infection, see Neonatal herpes simplex infection.
Herpes simplex encephalitis can usually be excluded and empirical therapy stopped based on negative CSF nucleic acid amplification test results (eg polymerase chain reaction [PCR]) and a normal MRI. However, test results for HSV in CSF can be negative in very early disease (before day 3 of illness); consider a repeat lumbar puncture and PCR if clinical suspicion is high.
Add empirical therapy for Listeria monocytogenes infection for patients at risk; this includes patients who:
- are older than 50 years
- are younger than 1 month (ie neonates)
- have immune compromise
- are pregnant
- have a history of hazardous alcohol consumption.
For adults, add to aciclovir:
benzylpenicillin 2.4 g intravenously, 4-hourly. For dosage adjustment in adults with kidney impairment, see benzylpenicillin dosage adjustment.benzylpenicillinbenzylpenicillinbenzylpenicillin
Benzylpenicillin is the preferred drug for Listeria infection because L. monocytogenes is intrinsically resistant to cephalosporins. However, benzylpenicillin may not be appropriate for patients who have penicillin hypersensitivity. For adults who report penicillin hypersensitivity, carefully assess the nature and severity of the reaction (see Principles of assessment of adults reporting antimicrobial hypersensitivity), and consider whether use of benzylpenicillin is precluded. If benzylpenicillin is not used, for adults, add:
trimethoprim+sulfamethoxazole 5+25 mg/kg up to 480+2400 mg intravenously, 6-hourly. For dosage adjustment in adults with kidney impairment, see trimethoprim+sulfamethoxazole dosage adjustment.trimethoprim + sulfamethoxazoletrimethoprim+sulfamethoxazoletrimethoprim+sulfamethoxazole
For management of neonates and children with possible L. monocytogenes infection, seek expert advice.
When the diagnosis is confirmed and a pathogen has been identified, modify treatment accordingly. Advice on directed therapy is included in these guidelines for:
- Herpes simplex encephalitis
- Japanese encephalitis and Murray Valley encephalitis viruses
- Listeria monocytogenes meningoencephalitis
- Toxoplasma gondii encephalitis
- Varicella zoster encephalitis.
If no pathogen is identified, seek specialist advice for further investigation and management (including consideration of antibody testing and immunotherapy for possible immune-mediated causes).